Credit Suisse’s IGM Biosciences IGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,607
Closed -$97.9K 3146
2023
Q2
$97.9K Sell
10,607
-604
-5% -$5.58K ﹤0.01% 3119
2023
Q1
$154K Buy
11,211
+2,823
+34% +$38.8K ﹤0.01% 3144
2022
Q4
$143K Buy
8,388
+2,944
+54% +$50.1K ﹤0.01% 3250
2022
Q3
$124K Buy
5,444
+54
+1% +$1.23K ﹤0.01% 3375
2022
Q2
$98K Buy
+5,390
New +$98K ﹤0.01% 3516
2021
Q4
Sell
-4,308
Closed -$283K 3664
2021
Q3
$283K Buy
4,308
+85
+2% +$5.58K ﹤0.01% 3271
2021
Q2
$351K Sell
4,223
-1,871
-31% -$156K ﹤0.01% 3201
2021
Q1
$468K Sell
6,094
-10,904
-64% -$837K ﹤0.01% 2991
2020
Q4
$1.5M Buy
16,998
+4,643
+38% +$410K ﹤0.01% 2310
2020
Q3
$911K Sell
12,355
-1,133
-8% -$83.5K ﹤0.01% 2332
2020
Q2
$985K Buy
+13,488
New +$985K ﹤0.01% 2332